Cargando…
The effects of reimbursement reform of antidiabetic medicines from the patients’ perspective – a survey among patients with type 2 diabetes in Finland
BACKGROUND: In Finland, the reimbursement rate for antidiabetic medicines other than insulins was lowered from 100 to 65% at the beginning of 2017. The objective of this study was to examine the effects of this reform experienced by patients with type 2 diabetes. The objective was also to explore if...
Autores principales: | Suviranta, Taika, Timonen, Johanna, Martikainen, Janne, Aarnio, Emma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819478/ https://www.ncbi.nlm.nih.gov/pubmed/31665003 http://dx.doi.org/10.1186/s12913-019-4633-9 |
Ejemplares similares
-
Reimbursement and use of oral anticoagulants during 2014–2022 - A register-based study
por: Aarnio, Emma, et al.
Publicado: (2023) -
Willingness to Pay for Implementation of an Environmentally Friendly Pharmaceutical Policy in Finland—A Discrete Choice Experiment Study
por: Alajärvi, Lasse, et al.
Publicado: (2022) -
Impact of co-payment level increase of antidiabetic medications on glycaemic control: an interrupted time-series study among Finnish patients with type 2 diabetes
por: Lavikainen, Piia, et al.
Publicado: (2020) -
The reasons behind medicine shortages from the perspective of pharmaceutical companies and pharmaceutical wholesalers in Finland
por: Heiskanen, Kati, et al.
Publicado: (2017) -
To Reform Pharmacy Reimbursement Begin with the Basics
por: Rupp, Michael T.
Publicado: (2020)